GLP-1 Providers That Accept Medicare

By WPG Research Team · Last verified: April 9, 2026 · Sources: CMS.gov, provider websites, KFF, FDA

10 providers verified3 confirmed Medicare-billing paths100-point compatibility rubricCMS Bridge FAQ cross-referencedUpdated April 9, 2026

Bottom line:

We verified every major online GLP-1 provider's Medicare policy. Only three clearly qualify as GLP-1 providers that accept Medicare for clinical visits right now: Form Health (best overall, 91/100), knownwell (best with no membership fee, 88/100), and Shapely (best if you live in CA, FL, NY, or TX, 76/100).

Starting July 1, 2026, the Medicare GLP-1 Bridge covers Wegovy, Zepbound KwikPen, and Foundayo at a flat $50/month for eligible Part D beneficiaries. None of the providers on this page are perfect — but these three are the only ones we found that actually work with your Medicare benefits.

Check Form Health plans →Check knownwell plans →Check Shapely (CA, FL, NY, TX) →

If you already know you want the cheapest cash-pay compounded option and are not trying to use Medicare, this page is not your best starting point. Head to our self-pay GLP-1 comparison instead. This page is built specifically for people who want to use their Medicare benefits.

Jump to section

Medicare Compatibility Matrix (10 Providers)
Form Health — Best Overall (91/100)
knownwell — Best No Membership Fee (88/100)
Shapely — Best in CA, FL, NY, TX (76/100)
Provider Acceptance vs Drug Coverage
Does Medicare Cover Wegovy, Zepbound, Ozempic?
The Medicare GLP-1 Bridge: Who Qualifies?
Original Medicare vs Medicare Advantage
What to Do If Your Medication Is Denied
Providers That Do NOT Accept Medicare
Best Fallback Paths If Medicare Won't Cover
How to Prepare for the Bridge Now
What Happens After the Bridge Ends?
FAQ: 13 Questions Answered

3 GLP-1 Providers That Accept Medicare — the clearest Medicare-friendly online options for clinical visits. Form Health (Best Overall): accepts Medicare, bills clinician visits, labs, and medications through insurance, FDA-approved medication path, requires a primary care visit within the last 12 months. knownwell (Best No Membership Fee Option): accepts Medicare, nationwide virtual care, no membership fee, transparent self-pay visit pricing. Shapely (Best in CA, FL, NY, and TX): accepts Original Medicare, accepts most Medicare Advantage PPO plans, available in California, Florida, New York, and Texas, includes dietitian support and insurance navigation. Important: Provider acceptance and medication coverage are not the same thing.

Which GLP-1 Providers That Accept Medicare Can You Actually Use?

Most online GLP-1 providers do not accept Medicare. We checked the insurance and billing pages for every major telehealth weight loss program as of April 2026 and scored them on a transparent 100-point rubric. The verified short list is small: Form Health, knownwell, and Shapely are the only three that clearly bill Medicare for clinician visits.

One thing most pages won't say plainly: A provider "accepting Medicare" and Medicare "covering your GLP-1 medication" are two completely different things. Your visit can be billed to Medicare while your prescription gets denied. That distinction shapes everything on this page.

Scoring Rubric

30 pts

Clearly accepts/bills Medicare for clinician visits

20 pts

Helps with insurance navigation and prior authorization

15 pts

Offers an FDA-approved medication path

15 pts

Geographic reach

10 pts

Transparent self-pay fallback if insurance fails

10 pts

Friction/trust factors (clarity, exclusions)

Medicare Compatibility Matrix — Verified April 9, 2026

Provider	Medicare Score	Accepts Medicare for Visits?	Helps with Prior Auth?	Medication Path	Self-Pay Fallback	Gov't Insurance Excluded?
Form Health	91/100	Bills visits and labs through Medicare	Insurance navigation built in	FDA-approved (Wegovy, Zepbound, Contrave, Saxenda)	$299/mo self-pay plan	No — accepts Medicare
knownwell	88/100	Accepts Medicare and most major plans	Yes	FDA-approved only	$299 first visit / $149 follow-up	No — accepts Medicare
Shapely	76/100	Original Medicare + most MA PPO in CA, FL, NY, TX	Yes	FDA-approved + compounded fallback	Copays as low as $15; compounded from $99	No — accepts Medicare in 4 states
Ro	39/100	Cannot coordinate government insurance	Commercial plans only	FDA-approved + cash-pay	$45 first mo / $145/mo + med cost	Yes — government insurance excluded
PlushCare	18/100	Dropped Medicare Part B Jan 2026; some MA may work	Limited	FDA-approved	Per-visit self-pay	Mostly — see text
Walgreens	8/100	Self-pay only, ages 18–64, no insurance	No	FDA-approved	$49/visit self-pay	Yes — no insurance billing
MEDVi	N/A	Cash-pay only	No	Compounded (not FDA-approved)	$179 first mo / $299 refills	Yes — cash-pay only
Eden	N/A	Not enrolled with Medicare/Medicaid	No	Compounded (not FDA-approved)	Cash-pay	Yes — cash-pay only
TrimRx	N/A	Direct-to-patient cash model	No	Compounded (not FDA-approved)	From $199/mo	Yes — cash-pay only
SkinnyRx	N/A	Not enrolled in Medicare/Medicaid	No	Compounded (not FDA-approved)	Cash-pay	Yes — cash-pay only

Sources: Form Health FAQ and insurance page (formhealth.co, April 2026), knownwell insurance page (knownwell.co, April 2026), Shapely Medicare page (getshapely.com, April 2026), provider insurance/terms pages. Verified April 9, 2026.

This table took five hours to assemble and cross-reference. You would need to open at least eight browser tabs and read the fine print on each provider's insurance page to build it yourself. We re-verify the full matrix monthly through 2026, and immediately after any CMS or provider policy change.

Best Overall for Most Medicare Beneficiaries: Form Health

Form Health

Best Overall91/100

Accepts Medicare · Bills visits + labs through insurance · FDA-approved anti-obesity medications only

See if Form Health accepts your plan

Form Health is the strongest verified answer for Medicare beneficiaries looking for an online GLP-1 provider because it explicitly accepts Medicare, bills clinician visits and labs through insurance, and stays exclusively on the FDA-approved anti-obesity medication side. It is staffed by board-certified obesity medicine physicians — not general practitioners who happen to prescribe GLP-1s on the side.

Why Form Health wins this comparison

It actually bills Medicare for visits and labs. Form Health's insurance page explicitly lists Medicare, alongside major commercial plans like Blue Cross Blue Shield, Cigna, Aetna, and UnitedHealthcare. When your visit is covered, you pay your plan's copay — not a separate subscription fee on top of your insurance.

It focuses on FDA-approved anti-obesity medications. Form Health names Wegovy, Zepbound, Contrave, and Saxenda in its public FAQ — drugs with FDA-approved weight management indications. Compounded GLP-1s cannot be billed to Medicare under any pathway. Form keeps you in the FDA-approved lane.

It has a self-pay fallback. If Medicare covers your visits but the medication itself gets denied, Form offers a $299/month self-pay program so you are not left stranded.

It requires an existing PCP relationship. You need a primary care provider and a PCP visit within the last 12 months. Some people will see that as friction. We see it as a feature — it builds on your existing medical team, which makes prior authorization requests stronger.

Best for

• Medicare beneficiaries who want visits billed to insurance
• Anyone planning to use the Bridge in July 2026
• People who prefer FDA-approved medications only

Honest tradeoff

Form Health is NOT the cheapest or fastest path. If you want $179/month compounded shipped in a week with no PCP requirement, Form is not built for that. But if you are on Medicare and want a provider that works with your coverage, Form is the cleanest verified path we found.

If you want a true Medicare-billed GLP-1 path, see if Form Health accepts your specific plan →

Best No-Membership-Fee Option: knownwell

knownwell

Best No Membership Fee88/100

Accepts Medicare · Nationwide virtual care · No membership fee · Transparent per-visit pricing

Check knownwell's Medicare availability

knownwell is the strongest second choice for Medicare beneficiaries who want a GLP-1 provider with no recurring subscription fee. It accepts Medicare and most major commercial insurance plans, offers nationwide virtual care, and charges nothing for membership — you pay per visit or your insurance copay.

No membership fees. Most telehealth GLP-1 programs charge $99–$199/month just for access to a provider, before the medication cost. knownwell does not. You pay per appointment — $299 for the first visit and $149 for follow-ups if self-paying, or your Medicare copay if your plan covers the visit.

Accepts Medicare with nationwide virtual coverage. knownwell's insurance page lists Medicare alongside major commercial plans, and its virtual care model is available nationwide — not locked to a handful of states.

Transparent self-pay pricing. If your Medicare plan does not cover knownwell as in-network, you know exactly what you will pay upfront. No hidden fees. No surprise charges after the visit.

Best for

• Medicare beneficiaries avoiding monthly subscriptions
• People outside Form Health's coverage area
• Beneficiaries who want per-visit billing with no commitment

Honest tradeoff

knownwell does NOT have the most detailed Medicare-specific onboarding experience. Form Health makes the Medicare pathway clearer during signup. But knownwell's no-fee structure and nationwide reach make it the best alternative when Form is not available or when you want to minimize ongoing costs.

If no membership fees matter to you, check whether knownwell is in-network with your Medicare plan →

Best if You Live in CA, FL, NY, or TX: Shapely

Shapely

Best in CA, FL, NY, TX76/100

Original Medicare + most MA PPO · CA, FL, NY, TX · Dietitian included · Copays as low as $15

Check Shapely Medicare plans

Shapely is the most straightforward Medicare match if you happen to live in one of its four states. Its Medicare page explicitly says it accepts Original Medicare and most PPO Medicare Advantage plans in California, Florida, New York, and Texas.

It names Medicare on a dedicated page. While many providers bury their insurance information, Shapely has a page specifically addressing Medicare acceptance. It publishes specific numbers: copays as low as $15 for visits and typical medication costs around $25 every 4 weeks for covered beneficiaries.

Both FDA-approved and compounded fallback paths. If your Medicare plan covers the visit but denies the branded medication, Shapely does not just send you away. It has self-pay programs including compounded options starting at $99, so you have a fallback within the same provider relationship.

Includes dietitian access. For Medicare beneficiaries, dietitian visits billed through Medicare are a meaningful benefit — especially because the Bridge and BALANCE programs both require lifestyle support alongside medication.

Only available in 4 states. Shapely does NOT serve all 50 states. If you live outside CA, FL, NY, or TX, this is not an option for you today.

If you live in CA, FL, NY, or TX, see if Shapely accepts your specific Medicare plan →

Which Medicare GLP-1 Path Fits You Best? Start with your real priority. I want the clearest Medicare-billed path → Form Health (accepts Medicare, bills visits, labs, and medications through insurance, FDA-approved medication path, best overall fit for most Medicare users). I want to avoid a monthly membership fee → knownwell (accepts Medicare, nationwide virtual care, no membership fee, transparent self-pay visit pricing). I live in CA, FL, NY, or TX → Shapely (accepts Original Medicare, accepts most Medicare Advantage PPO plans, available in California, Florida, New York, and Texas, includes dietitian support). My medication is denied or I want a cash-pay fallback → Self-Pay Fallback Path (separate from Medicare acceptance, out-of-pocket path, best used only after checking Medicare-friendly options first). Best practice: start with Medicare-friendly care first, then decide whether you need a fallback path.

Medicare Acceptance and Medicare Drug Coverage Are Not the Same Thing

This is the section that stops the back-and-forth searching. If you take one thing from this page, make it this:

Visit Side

"Accepts Medicare" means the provider bills your Medicare plan for clinical visits

The doctor appointment, lab orders, dietitian consultations. This is the visit side. Form Health, knownwell, and Shapely pass this test.

Medication Side

"Medicare covers the drug" means Part D pays for the actual medication

Wegovy, Zepbound, Ozempic, or Mounjaro. This requires separate prior authorization, separate approval criteria, and a formulary check. This is where most people hit a wall.

You can have a Medicare-billed visit with Form Health on Monday and get your Wegovy prescription denied by your Part D plan on Tuesday. That is not Form Health's fault. It is how Medicare drug coverage works.

Provider Accepts Medicare vs Medication Covered by Medicare — these are two different approval steps. Provider Accepts Medicare (left): Covers the clinical visit side; may include doctor visits, labs, and dietitian care; depends on whether the provider bills Medicare or your plan. Medication Covered by Medicare (right): Covers the prescription side; may require formulary review and prior authorization; a covered visit does not guarantee a covered GLP-1 prescription. You can have a Medicare-covered visit and still have the medication denied. Steps: 1. Choose a Medicare-friendly provider, 2. Check medication coverage rules, 3. Have a fallback plan if the drug is denied.

Does Medicare Cover Wegovy, Zepbound, Ozempic, or Mounjaro in 2026?

Under standard Part D rules as of April 2026, Medicare still does not cover GLP-1 medications prescribed solely for weight loss. The exceptions are specific FDA-approved indications and the temporary Medicare GLP-1 Bridge launching July 1, 2026. Here is the drug-by-drug breakdown:

Medicare GLP-1 Drug Coverage Matrix — April 2026

Medication	Covered by Standard Part D?	Covered by GLP-1 Bridge ($50/mo)?	For What Indication?
Wegovy (semaglutide injection + oral tablet)	Only for cardiovascular risk reduction in adults with established CVD who are overweight/obese	Yes — for weight loss in eligible beneficiaries	CVD risk reduction (Part D) or weight loss (Bridge)
Zepbound KwikPen (tirzepatide injection)	Only for moderate-to-severe obstructive sleep apnea in adults with obesity	Yes — for weight loss in eligible beneficiaries	Sleep apnea (Part D) or weight loss (Bridge)
Foundayo (orforglipron — oral pill, FDA-approved April 1, 2026)	Not covered for weight loss under standard Part D exclusion	Yes — added to Bridge as of April 6, 2026	Weight loss (Bridge pathway only)
Ozempic (semaglutide injection)	For Type 2 diabetes management	No — not included in Bridge	Type 2 diabetes only
Mounjaro (tirzepatide injection)	For Type 2 diabetes management	No — not included in Bridge	Type 2 diabetes only
Any compounded GLP-1	Never covered	Never covered	N/A — not FDA-approved

Sources: CMS Medicare GLP-1 Bridge FAQ (cms.gov, updated April 6, 2026), FDA drug approval pages, KFF analysis (March 2026), Eli Lilly Foundayo approval announcement.

What This Means in Plain English

If you have Type 2 diabetes: Your Part D plan likely already covers Ozempic or Mounjaro. Weight loss is a documented benefit even though the prescription is written for diabetes. You may not need the Bridge at all.

If you have cardiovascular disease and are overweight/obese: Wegovy may be coverable under your Part D plan right now for CVD risk reduction. This is a standard Part D benefit, not the Bridge.

If you have moderate-to-severe obstructive sleep apnea with obesity: Zepbound may be coverable under your Part D plan right now — standard benefit, not the Bridge.

If you want a GLP-1 specifically for weight loss without those conditions: The Bridge program starting July 1, 2026 is your first realistic Medicare pathway. Until then, cash-pay is your only option.

If you want compounded semaglutide or tirzepatide: Medicare will not cover it. Period. Not under Part D, not under the Bridge, not under BALANCE in 2027. Compounded medications have not undergone the FDA approval process required for Medicare coverage.

What Is the Medicare GLP-1 Bridge, and Who Qualifies?

The Medicare GLP-1 Bridge is a temporary CMS demonstration program running from July 1, 2026 through December 31, 2026. It is the first time in over 20 years that Medicare has covered any prescription medication specifically for weight loss. Eligible beneficiaries pay a flat $50/month copay for Wegovy, Zepbound KwikPen, or Foundayo.

Bridge Program Quick Facts

Detail	What You Need to Know
Dates	July 1 – December 31, 2026
Drugs covered	Wegovy (injection + oral tablet), Zepbound KwikPen, Foundayo (orforglipron — added April 6, 2026)
Your cost	$50/month flat copay
Who runs it	CMS, with Humana as the central processor — NOT your Part D plan
Enrollment needed?	No separate enrollment. You must be in a qualifying Part D PDP or MA-PD coordinated-care plan.
Prior authorization?	Yes — your doctor submits PA to the CMS central processor, not to your Part D plan
Telehealth allowed?	Yes — the prescribing provider does not need to be enrolled in Medicare, just not on the Preclusion List
After December 2026?	BALANCE Model begins Jan 2027 for participating Part D plans — check your plan during Open Enrollment

Source: CMS Medicare GLP-1 Bridge FAQ (cms.gov, updated April 6, 2026).

Who Qualifies — The Actual CMS Criteria

Most articles simplify the Bridge eligibility criteria. You must be on a qualifying Part D plan, age 18+, currently on or willing to start lifestyle modification, AND meet one of these three clinical thresholds at the time GLP-1 therapy was initiated:

Threshold 1

BMI ≥ 35 at GLP-1 initiation — qualifies on its own

Threshold 2

BMI ≥ 30 at GLP-1 initiation PLUS heart failure with preserved ejection fraction (HFpEF), uncontrolled hypertension, or chronic kidney disease stage 3a or higher

Threshold 3

BMI ≥ 27 at GLP-1 initiation PLUS prediabetes, prior myocardial infarction (heart attack), prior stroke, or symptomatic peripheral artery disease

Critical detail most articles miss:

CMS judges eligibility at the time therapy was initiated, not at the date of your PA request. If you started GLP-1 treatment in 2024 with a BMI of 37 and your BMI has since dropped to 33, your doctor can attest to your BMI at therapy initiation. You are not disqualified because the medication is working.

Another detail most articles miss:

The prescribing provider does NOT need to be enrolled in Medicare to write the Bridge prescription — just cannot be on CMS's Preclusion List. Even telehealth providers that don't normally "accept Medicare" can technically write a Bridge-eligible prescription. But you will want a provider experienced with the PA process, which is why Form Health and knownwell are still your best bet.

What the $50 Copay Does NOT Do

The $50/month Bridge copay does NOT count toward your Part D plan's $2,100 annual out-of-pocket spending cap. Bridge costs will not help you reach catastrophic coverage faster.

Low-income Medicare beneficiaries who qualify for reduced cost-sharing through the Part D Low-Income Subsidy (LIS) cannot use those subsidies for Bridge program prescriptions. For some, $50/month may still be a barrier — and that is worth knowing upfront.

The Bridge Timeline You Need to Follow

When	What to Do
Now (April 2026)	Verify Part D enrollment. Schedule a doctor visit. Get your BMI documented. Discuss Wegovy, Zepbound, or Foundayo with your provider.
May–June 2026	Ask your provider to prepare the prior authorization paperwork for the CMS central processor. Final PA guidance expected Spring 2026.
July 1, 2026	Bridge launches. Fill your first prescription at $50/month.
Oct 15–Dec 7, 2026	Open Enrollment. Check whether your Part D plan participates in the BALANCE Model for 2027. If not, consider switching.
Dec 31, 2026	Bridge ends.
Jan 1, 2027	BALANCE Model begins for participating plans.

Think you qualify for the Bridge? The smartest move right now is scheduling a visit with Form Health or knownwell to get your documentation ready before July.

See if Form Health accepts your plan →Check knownwell Medicare availability →

Original Medicare vs. Medicare Advantage: Which Is Easier for GLP-1 Access?

Plan Type	Bridge Eligible?	Notes
Original Medicare + standalone PDP	Yes	Maximum provider flexibility — any Medicare-accepting provider
Medicare Advantage PPO with drug coverage (MA-PD)	Yes	May allow out-of-network telehealth at higher cost-sharing
Medicare Advantage HMO with drug coverage (MA-PD)	Yes	More restrictive networks — confirm provider is in-network
Original Medicare WITHOUT Part D	No	Must have Part D drug coverage to qualify
Medicare Supplement (Medigap) only	No	Medigap does not include drug coverage

Source: CMS Medicare GLP-1 Bridge FAQ (cms.gov, April 2026). Verify your specific plan type's eligibility.

The Bridge itself works the same regardless of your Medicare flavor — $50/month, same drugs, same central processor. The difference is on the visit side: check whether your specific plan covers the specific provider you want to use. Call the provider's insurance line before your first appointment. Shapely specifically calls out Medicare Advantage PPO acceptance in its four states — a clean match if you have an MA PPO in CA, FL, NY, or TX.

What Happens If Your Provider Accepts Medicare but Your Medication Is Denied?

This is where most people give up and start the whole search over. A medication denial does not mean the end of the road. It means you need to figure out why it happened and what to do next.

The 4 Most Common Denial Reasons

Wrong indication. Your prescription was written for "weight loss" but your Part D plan only covers the drug for diabetes, CVD risk reduction, or sleep apnea. This is the most common barrier. The Bridge program (July 2026) was designed specifically to close this gap.

Formulary exclusion. The specific drug is not on your Part D plan's formulary. Every plan has a different drug list. Just because Wegovy exists does not mean your plan covers it.

Prior authorization not submitted or incomplete. Many denials are paperwork failures, not medical ones. Incomplete submissions — missing BMI documentation, missing comorbidity records, missing lifestyle modification attestation — are a leading cause. This is where having a provider with PA experience makes a measurable difference.

Step therapy requirement. Your plan requires you to try a less expensive medication first before approving the one you want.

Your Denial Response Playbook

Step 1: Read the denial letter.

It will state the specific reason. Do not guess.

Step 2: Gather your documentation.

BMI history (current and at therapy initiation), list of qualifying comorbidities with diagnostic codes, evidence of previous weight loss attempts, and your provider's clinical notes supporting medical necessity.

Step 3: Decide your next move.

If it is an indication issue and the Bridge is live: Ask your provider to resubmit through the Bridge pathway.
If it is a formulary issue: Ask your provider to request a formulary exception — you have the right to this under Part D rules.
If it is a PA failure: Resubmit with complete documentation. Consider switching to a provider with dedicated PA support.
If it is a step therapy issue: Ask your doctor whether trying the required first-step drug makes clinical sense. If not, request a step therapy exception.

Step 4: If the appeal fails,

move to one of the self-pay fallback paths below. That does not mean you failed — it means the system was not built for your specific case yet.

For a deeper walkthrough on prior authorization timelines and appeal strategies: our prior authorization guide →

Before You Book a GLP-1 Provider With Medicare — 4 things to verify first. 1. Does the provider accept Medicare for visits? A provider can bill Medicare for care even if the medication is handled separately. 2. Does your specific plan match the provider? Original Medicare and Medicare Advantage can work differently. 3. How will the medication be handled? Prescription coverage may depend on formulary rules and prior authorization. 4. What is your fallback plan if the drug is denied? Know your next step before you start. The smartest path is the one that answers both questions: Can I use Medicare for care? What happens if the prescription is denied?

Which Popular Online GLP-1 Providers Do NOT Accept Medicare?

These are legitimate providers with real patients — they just are not the right answer for people searching for GLP-1 providers that accept Medicare.

Ro — Cash-pay membership, not a true Medicare path

Ro explicitly states it cannot coordinate GLP-1 coverage for government insurance plans, including Medicare and Medicaid. Its Body Program membership is cash-pay: $45 for the first month, then $145/month ongoing. Medicare beneficiaries can join Ro and pay out of pocket, but Ro will not bill Medicare or navigate Medicare coverage.

Provider says: Cannot coordinate government insurance for GLP-1 coverage. Medicare users can join and pay cash for certain options. Verified: Confirmed on Ro's insurance FAQ (ro.co) as of April 9, 2026.

PlushCare — Medicare Part B no longer accepted

PlushCare dropped Medicare Part B acceptance as of January 1, 2026. Some Medicare Advantage plans may still be accepted, but the policy is narrow enough that we cannot recommend it as a reliable Medicare path. If you have an MA plan, call PlushCare directly to verify before booking.

Walgreens Virtual Weight Management — Not built for Medicare users

Walgreens lists its weight management visit as a $49 self-pay service for ages 18–64 and explicitly does not handle insurance or prior authorizations. Medicare beneficiaries are typically 65+, and the lack of insurance billing and PA support makes this the wrong doorway.

LifeMD — Mixed signals on Medicare

LifeMD's support pages present conflicting information. One page states it accepts Medicare Fee-For-Service for qualifying virtual care in some states; another page says it does not accept insurance for its GLP-1 weight loss programs. Because the messaging is contradictory, we cannot list LifeMD as a clear Medicare path. Contact them directly and get written confirmation before booking.

MEDVi — Cash-pay compounded only

MEDVi operates on a direct cash-pay model. Compounded semaglutide starts at $179 for the first month, with refills at $299/month. It does not accept Medicare or any insurance. It is a legitimate option for people who want compounded treatment and are comfortable paying out of pocket — but it is a self-pay fallback, not a Medicare answer.

Eden — Cash-pay, not enrolled with Medicare

Eden's terms of service state it is not enrolled with federal or state programs including Medicare and Medicaid. All services are cash-pay.

TrimRx — Cash-pay compounded, no Medicare billing

TrimRx has published that compounded medications are generally not covered by Medicare and that its program operates on a direct-to-patient cash-pay model. Compounded semaglutide starts at $199/month.

SkinnyRx — Cash-pay, not enrolled in Medicare

SkinnyRx's terms state that it and its affiliated providers are not enrolled in Medicare or Medicaid and do not accept health insurance. All services are cash-pay.

The pattern is clear: the vast majority of online GLP-1 programs are built for cash-pay or commercial insurance customers. Medicare beneficiaries have fewer options — which is exactly what makes Form Health, knownwell, and Shapely worth knowing about.

If Medicare Won't Cover Your Medication: The Best Fallback Paths

You have done everything right — picked a Medicare-friendly provider, submitted the prior authorization, maybe even appealed — and the answer is still no. Or maybe July 2026 feels too far away. Here are your options, organized by what matters most to you.

Medicare Beneficiary Self-Pay Fallback Matrix

Fallback Path	Monthly Cost	Medication Type	Medicare Users Eligible?	Notes
Wegovy oral tablet (NovoCare self-pay)	$149/mo (1.5mg–4mg doses)	FDA-approved	Government beneficiaries excluded	Novo Nordisk terms explicitly exclude Medicare patients even when self-paying
Wegovy pen via Ro (cash-pay)	$199 first mo, $199–$349 thereafter + $45/$145 membership	FDA-approved	Can join Ro and pay cash	Ro cannot bill Medicare but allows cash-pay enrollment
MEDVi compounded	$179 first mo, $299/mo refills	Compounded (not FDA-approved)	Cash-pay, no insurance check	Lowest entry-point for compounded among major providers
TrimRx compounded	From $199/mo	Compounded (not FDA-approved)	Cash-pay	Direct-to-patient model
Shapely compounded fallback	From $99/mo	Compounded (not FDA-approved)	Available as fallback within Shapely	Only in CA, FL, NY, TX
Medicare GLP-1 Bridge (July 2026)	$50/mo	FDA-approved (Wegovy, Zepbound KwikPen, Foundayo)	If you meet eligibility criteria	Temporary: July 1 – Dec 31, 2026

All pricing verified April 9, 2026. Pricing may change — verify directly with providers before committing.

The NovoCare exclusion you need to know about:

Novo Nordisk's self-pay Wegovy pricing ($149–$349/month) sounds like an obvious fallback for Medicare patients who get denied coverage. But NovoCare's terms explicitly exclude government beneficiaries — including Medicare patients — from its savings programs and self-pay pricing, even if you elect to pay entirely out of pocket. This is a manufacturer restriction, not a provider restriction.

If You Want FDA-Approved Medication at Cash-Pay Pricing

Ro Body Program: Medicare beneficiaries can join Ro and pay cash. Wegovy pen is $199 for the first month, then $199–$349/month depending on dose, plus Ro's membership ($45 first month, $145/month ongoing). Currently the most accessible FDA-approved cash-pay path for Medicare patients, since Ro does not run NovoCare eligibility checks that would exclude government beneficiaries.

If Budget Is the Priority and You Understand the Compounded Tradeoff

Compounded GLP-1 medications are NOT FDA-approved. They are prepared by licensed compounding pharmacies based on a doctor's prescription, but they have not undergone the FDA's approval process for safety, efficacy, and manufacturing quality. Medicare will never cover them.

With that clearly stated — for Medicare beneficiaries on a fixed income who cannot afford $344–$494/month for branded Wegovy through Ro and cannot wait until July for $50/month Bridge pricing, compounded programs offer a significantly lower entry point.

MEDVi — Best Compounded Cash-Pay Fallback

Lowest Entry PriceNo Insurance Required

$179 first month · $299/mo refills · Month-to-month · No contracts

Check MEDVi eligibility

MEDVi starts at $179 for the first month of compounded semaglutide, with refills at $299/month. Month-to-month billing, no contracts. It does not accept Medicare or any insurance. But for Medicare beneficiaries who need to start before July 2026 and can't afford branded pricing, it is the lowest verified entry price among major compounded providers.

Important: MEDVi offers compounded semaglutide, not FDA-approved brand-name medications like Wegovy or Zepbound. Compounded medications are not FDA-approved and will never be covered by Medicare.

If you need to start before July and budget matters → Check MEDVi ($179 first month)

Other Cash-Pay Compounded Alternatives

TrimRx

Compounded semaglutide from $199/month. Direct-to-patient model, no insurance requirement. Verify current pricing at trimrx.com.

See TrimRx pricing

Eden

Both compounded and FDA-approved medication options available. Cash-pay, no insurance billing. Verify current pricing at edentelemed.com.

See Eden pricing

SkinnyRX

Budget-focused compounded semaglutide. Cash-pay, straightforward pricing. Verify at skinnyrx.com.

See SkinnyRX pricing

How to Prepare for the Medicare GLP-1 Bridge Right Now

The Bridge does not launch until July 1, 2026. But the beneficiaries who fill their first prescription on day one will be the ones who prepared in April, May, and June. Here is your action plan:

Verify your Part D enrollment (5 minutes).

Log into Medicare.gov or call 1-800-MEDICARE (1-800-633-4227). Confirm you are enrolled in a qualifying PDP or MA-PD plan for 2026.

Schedule a doctor visit this month.

See your PCP or a Medicare-accepting GLP-1 telehealth provider (Form Health, knownwell, or Shapely). Get your BMI measured and documented, discuss your weight history and qualifying comorbidities, tell your doctor you want to be ready for the Bridge, and ask your doctor to note your BMI at therapy initiation if you have used a GLP-1 previously.

Build your prior authorization file (May 2026).

Gather: current BMI measurement, BMI at therapy initiation (if applicable), diagnostic records for qualifying comorbidities, documentation of lifestyle modification, and your provider's clinical notes supporting medical necessity.

Watch for CMS Spring 2026 updates.

Final PA guidance, appeals process details, and operational information are expected soon. Check the CMS Bridge page or ask your provider.

Plan for 2027 now.

During Open Enrollment (October 15 – December 7, 2026), check whether your Part D plan participates in the BALANCE Model. BALANCE is voluntary — not every plan will join. If yours does not, consider switching to maintain GLP-1 weight loss coverage without a gap.

Get your documentation ready before July — start with a Medicare-accepting provider:

Check Form Health plans →Check knownwell availability →Check Shapely (CA, FL, NY, TX) →

What Happens After the Bridge Ends in December 2026?

The Bridge is temporary — six months. After December 31, 2026, your GLP-1 weight loss coverage depends on the BALANCE Model.

BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) is a CMS Innovation Center demonstration model, not a permanent benefit change. It launches in Medicare Part D in January 2027 for plans that choose to participate.

The critical difference: BALANCE is voluntary for Part D plans. Your plan may or may not participate. If it does not, you lose Medicare GLP-1 weight loss coverage on January 1, 2027 — unless you switch to a participating plan during Open Enrollment. Check your plan's BALANCE participation status in October 2026 and make your enrollment decision with that information.

How We Verified These Providers

Sources used: CMS.gov (Medicare GLP-1 Bridge FAQ, BALANCE Model page), FDA drug approval pages, Eli Lilly investor announcements, KFF analysis (March 2026), and each provider's current public-facing insurance/FAQ/pricing pages as of April 9, 2026.

Score rubric: The Medicare Compatibility Score is our editorial assessment based on the 100-point rubric published in the comparison table. It reflects how well each provider serves someone searching for "GLP-1 providers that accept Medicare" — not a general quality rating.

What "Last verified" means: Every data point in the comparison matrix was checked against the provider's live website on April 9, 2026. We re-verify monthly through 2026 and immediately after any CMS, FDA, or provider policy change.

What we did NOT do: We did not use fake review schema, star ratings without real data, or aggregated scores from unverified platforms. Testimonials are clearly labeled as patient stories from provider websites.

Related Guides & Comparisons

Frequently Asked Questions: GLP-1 Providers & Medicare

For most Medicare beneficiaries, Form Health is the strongest verified option. It explicitly accepts Medicare, bills clinician visits and labs through insurance, and prescribes FDA-approved anti-obesity medications. knownwell is the best alternative with no membership fee, and Shapely is the strongest choice in California, Florida, New York, and Texas.

Not for weight loss alone under standard Part D rules as of April 2026. Wegovy is covered for cardiovascular risk reduction in adults with established CVD who are overweight or obese. Starting July 1, 2026, the Medicare GLP-1 Bridge will cover Wegovy for weight loss at $50/month for eligible beneficiaries in qualifying Part D plans.

Under standard Part D, Zepbound may be covered for moderate-to-severe obstructive sleep apnea in adults with obesity. The Medicare GLP-1 Bridge will also cover Zepbound KwikPen for weight loss starting July 2026 at $50/month.

Foundayo (orforglipron) is an oral GLP-1 pill manufactured by Eli Lilly, FDA-approved for obesity and overweight weight reduction on April 1, 2026. CMS added Foundayo to the Medicare GLP-1 Bridge as of April 6, 2026 — making it the first daily oral GLP-1 covered under the Bridge.

No. Ozempic is FDA-approved for Type 2 diabetes, not weight loss, and Medicare Part D covers it only for diabetes management. It is not included in the Bridge program. However, weight loss is a well-documented benefit of Ozempic treatment for diabetes.

No. Ro cannot coordinate GLP-1 coverage for government insurance plans including Medicare. Its Body Program is a cash-pay membership. Medicare beneficiaries can join Ro and pay out of pocket.

Yes. Form Health explicitly lists Medicare on its insurance page and bills clinician visits and labs through Medicare. It is our top-rated verified Medicare GLP-1 provider as of April 2026.

Yes. knownwell's insurance page lists Medicare alongside major commercial plans, with nationwide virtual care availability and no membership fee.

No. Compounded medications are not FDA-approved and cannot be covered under Medicare Part D, the GLP-1 Bridge, or any Medicare pathway. Compounded GLP-1 treatment is always cash-pay.

No. NovoCare's terms explicitly exclude government beneficiaries — including Medicare patients — from savings programs and self-pay pricing, even if you choose to pay entirely out of pocket. This is a manufacturer policy, not a provider decision.

BMI of 35 or higher at therapy initiation qualifies alone. BMI of 30 or higher qualifies with HFpEF, uncontrolled hypertension, or CKD stage 3a or higher. BMI of 27 or higher qualifies with prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease. Eligibility is judged at the time therapy was initiated, not at your PA request date.

Yes. Under the Bridge program, your provider submits the prior authorization to a CMS central processor administered by Humana, not to your individual Part D plan.

The Bridge is a temporary six-month program from July 1 through December 31, 2026, available to eligible beneficiaries in qualifying Part D plans at $50/month. BALANCE is the longer-term voluntary model starting January 1, 2027 for Part D plans that opt in — not every plan will join.

Your Next Step

You now know the verified list: Form Health, knownwell, and Shapely are the only three online GLP-1 providers that clearly bill Medicare for clinical visits. The Bridge program opens July 1 at $50/month. Your preparation window is right now.

For the clearest Medicare-billed path:

Form Health — Best Overall →knownwell — No Membership Fee →Shapely — CA, FL, NY, TX →

If insurance is a dead end and you need to start now:

Check MEDVi — $179 first month, no Medicare required

Affiliate Disclosure

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when you visit a provider through our links, at no additional cost to you. Our editorial assessments are based on publicly available information verified on the dates noted. We do not accept payment for higher rankings or scores. Not all providers listed are affiliate partners — Form Health, knownwell, and Shapely are not affiliate partners and are included because they are the verified answer to this query.

This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication. Medicare coverage rules, provider policies, and pricing can change — verify current details directly with your provider and plan before making decisions.

Last Verified: April 9, 2026 · Pricing Verified: April 9, 2026

Full editorial policy · How we make money